Device type is the second tier of market taxonomy, influencing procurement strategies and clinical outcomes. Synthetic mesh devices remain the largest category, accounting for approximately 55 % of total device revenue; their prevalence stems from proven tensile strength, cost efficiency, and broad regulatory acceptance. Biologic mesh devices, which comprise about 20 % of the market, are distinguished by their collagen‑based composition that promotes tissue integration and reduces infection risk, making them preferred in contaminated fields. Hybrid mesh devices, integrating synthetic and biologic layers, hold an estimated 15 % share and are gaining traction where surgeons seek a balance between durability and biocompatibility. Suture‑based fixation systems, representing roughly 10 % of sales, are essential for laparoscopic procedures that require precise mesh anchoring without excessive foreign material. This market taxonomy of device types clarifies how innovation, pricing pressure, and clinical guidelines redistribute market share across sub‑categories, thereby shaping overall growth trajectories through 2030, influencing investment decisions.